Advanced search
Publication Cover
Journal of Medical Economics Volume 24, 2021 - Issue 1
Submit an article Journal homepage
4,239
Views
11
CrossRef citations to date
0
Altmetric
Oncology

Cost-effectiveness of pembrolizumab compared with chemotherapy in the US for women with previously treated deficient mismatch repair or high microsatellite instability unresectable or metastatic endometrial cancer

Elizabeth Thurgara BresMed Health Solutions Ltd, Sheffield, UK
,
Mark Gouldsona BresMed Health Solutions Ltd, Sheffield, UK
,
Suzette Matthijsseb BresMed Netherlands, Utrecht, The Netherlands
,
Mayur Amonkarc Merck & Co. Inc., Kenilworth, NJ, USA
,
Patricia Marinelloc Merck & Co. Inc., Kenilworth, NJ, USA
,
Navneet Upadhyayc Merck & Co. Inc., Kenilworth, NJ, USA
,
Chizoba Nwankwoc Merck & Co. Inc., Kenilworth, NJ, USA
&
Raquel Aguiar-Ibáñezd Merck Canada Inc., Kirkland, CanadaCorrespondence[email protected]
 show all
Pages 675-688 | Received 07 Oct 2020, Accepted 08 Apr 2021, Published online: 13 May 2021

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.